SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• SALL2, a Spalt-like family transcription factor, is implicated in development and cancer, with proposed tumor suppressor roles.
• Its precise mechanisms in cancer, particularly regarding cell proliferation, remain largely unelucidated.
• SALL2 is linked to fundamental cellular processes including stemness, cell death, proliferation, and quiescence.

Purpose of the Study:

• To investigate the role of SALL2 in regulating cell proliferation.
• To elucidate the molecular mechanisms by which SALL2 controls the cell cycle.
• To confirm the tumor suppressor function of SALL2 in cancer contexts.

Main Methods:

• Utilized mouse embryo fibroblasts (MEFs) from Sall2 knockout and wild-type mice.
• Performed quantitative real-time PCR and Western blotting to assess gene and protein expression.
• Conducted chromatin immunoprecipitation and promoter reporter assays to determine SALL2's transcriptional regulation.
• Analyzed SALL2 and G1-S cyclin expression correlations in mouse tissues and human cancer datasets.

Main Results:

• Sall2-deficient MEFs exhibited significantly enhanced proliferation and accelerated G1 and S phase progression compared to wild-type MEFs.
• Sall2-deficient MEFs showed increased mRNA and protein levels of cyclins D1 and E1.
• SALL2 was found to directly bind and repress the promoters of CCND1 and CCNE1.
• Inverse correlation between SALL2 expression and G1-S cyclins was observed in mouse tissues and human cancers.
• Sall2-deficient MEFs demonstrated increased growth rate, foci formation, and anchorage-independent growth, indicative of tumor suppressor activity.

Conclusions:

• SALL2 acts as a negative regulator of cell proliferation, partly through the repression of G1-S cyclins (CCND1 and CCNE1).
• The findings support SALL2's role as a tumor suppressor.
• This study provides novel mechanistic insights into SALL2's function in cell cycle control and its significance in physiological and pathological conditions, including cancer.